Cadrenal Therapeutics shares owned by UBS Group
Quarter-by-quarter ownership of Cadrenal Therapeutics (CVKD) shares owned by UBS Group
from 13F filings
Historical chart of UBS Group investment in Cadrenal Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Cadrenal Therapeutics held by UBS Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Cadrenal Therapeutics by UBS Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $484 | 35 | 13.83 |
| 2025-06-30 | $3.9k | 326 | 12.00 |
| 2025-03-31 | $149k | 8.4k | 17.63 |
| 2024-12-31 | $32k | 2.2k | 14.49 |